Latin America Oxygen Therapy Market

Latin America Oxygen Therapy Market worth 0.49 Billion USD by 2021
Latin America Oxygen Therapy Devices Market was worth USD 0.25 billion in 2016 and
estimated to be growing at a CAGR of 6.93%, to reach USD 0.49 billion by 2021. Oxygen
therapy involves administering oxygen through an external device.
Oxygen Therapy devices are useful especially for people suffering from severe COPD or
cystic fibrosis who suffer from chronically low oxygen levels in their body. Advantages of
oxygen therapy also include increased mental stamina, aversion of heart failure, and an
enhanced breathing pattern. The administration and supply of supplementary oxygen have
turned into an indispensable part in the management of numerous diseases. Furthermore,
oxygen therapy is applicable to numerous diseases, for example, asthma, respiratory distress
syndrome, and obstructive sleep apnoea. Long-term oxygen treatments in patients suffering
from chronic lung disease are believed to enhance the length and the quality of life.
View Full Report: http://marketdataforecast.com/market-reports/latin-americaoxygen-therapy-market-3692/
The growth of the Latin America oxygen therapy market is mainly driven by the rise in different
respiratory diseases and the increasing awareness among general population regarding
personal health. The Latin America region is expected to offer a lucrative market in the future
due to the increasing elderly population who require home-based oxygen
therapy. Furthermore, increasing application of oxygen supply is expected to further boost
the growth of the market. Be that as it may, poor compensation and high cost of equipment
are preventing growth of the market. Despite the fact that the Latin America oxygen therapy
devices market is expecting hindrances due to a couple of restrictions, it will discover new
development opportunities in growing economies.
Request For Sample Brochure: http://marketdataforecast.com/marketreports/latin-america-oxygen-therapy-market-3692/request-sample
•
•
•
•
•
•
•
Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Oxygen Source Equipment
5.1.2.1 Oxygen Concentrators
5.1.2.1.1 Fixed Oxygen Concentrators
5.1.2.1.2 Portable Oxygen Concentrators
5.1.2.2 Liquid Oxygen Devices
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
5.1.2.3 Oxygen Cylinders
5.1.3 Oxygen Delivery Devices
5.1.3.1 Oxygen Masks
5.1.3.2 Nasal Cannulas
5.1.3.3 Venturi Masks
5.1.3.4 Non-Rebreather Masks
5.1.3.5 Bag Valve Masks
5.1.3.6 Other Devices
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
Portability
5.2.1 Introduction
5.2.2 Stationary Oxygen Therapy Devices
5.2.3 Portable Oxygen Therapy Devices
5.2.4 Y-o-Y Growth Analysis, By Portability
5.2.5 Market Attractiveness Analysis, By Portability
5.2.6 Market Share Analysis, By Portability
Application
5.3.1 Introduction
5.3.2 Chronic Obstructive Pulmonary Disease
5.3.3 Asthma, Obstructive Sleep Apnea
5.3.4 Respiratory Distress Syndrome
5.3.5 Cystic Fibrosis
5.3.6 Pneumonia
5.3.7 Y-o-Y Growth Analysis, By Application
5.3.8 Market Attractiveness Analysis, By Application
5.3.9 Market Share Analysis, By Application
End User
5.4.1 Introduction
5.4.2 Home Care Settings
5.4.3 Hospitals
5.4.4 Ambulatory Surgical Centers & Physician Offices
5.4.5 Others
5.4.6 Y-o-Y Growth Analysis, By End User
5.4.7 Market Attractiveness Analysis, By End User
5.4.8 Market Share Analysis, By End User
The Latin America oxygen therapy devices market is segmented into product type, application
and end user. On the basis of product, it is segmented into Oxygen Source Equipment,
Cylinders, Concentrators, Liquid Oxygen Devices, PAP, Oxygen Delivery Device, Masks,
Nasal Cannula, Venturi Mask, Non-Rebreather Mask, Bag Valve and CPAP. Oxygen source
equipment are expected to grow at 11% CAGR It is attributed to the consolidation of this
equipment in the extensive variety of uses as the first line of treatment. On the basis of
application, it is segmented into Chronic Obstructive Pulmonary Disease, Asthma,
Obstructive Sleep Apnoea, Respiratory Distress Syndrome, Cystic Fibrosis, Pneumonia.
Chronic obstructive pulmonary disease holds the largest share of the application segment
and it is anticipated to grow lucratively at a CAGR of over 10.5% over the next five years.
This is due to increasing popularity of supplemental administration in conjunction with first
line treatments available for COPD. Moreover, this treatment includes faster response rates,
reliability and portability, and above all improves chances of survival. On the basis of end use
it is segmented into Home Healthcare and Hospitals. Home health care dominates the enduse segment, owing to the rise in elderly population coupled with increasing number of
patients with low mobility and long-term care requirement in conditions such as Alzheimer’s
disease.
Inquire Before Buying: http://marketdataforecast.com/market-reports/latinamerica-oxygen-therapy-market-3692/inquire
Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnoea, Respiratory
Distress Syndrome, Cystic Fibrosis, Pneumonia. Chronic obstructive pulmonary disease
holds the largest share of over 36.0% of the application segment and it is anticipated to grow
lucratively at a CAGR of over 10.5% over the next five years. This is due to increasing
popularity of supplemental administration in conjunction with first line treatments available for
COPD. Moreover, this treatment includes faster response rates, reliability and portability, and
above all improves chances of survival. On the basis of end use it is segmented into Home
Healthcare and Hospitals). Home health care dominates the end-use segment with a
significant share of over 70%, owing to the rise in elderly population coupled with increasing
number of patients with low mobility and long-term care requirement in conditions such as
Alzheimer’s disease.
The Latin America region is geographically segmented into Mexico, Argentina and Brazil.
Latin America is expected to be a promising region for oxygen therapy devices and is stated
to witness rapid growth in the coming years. Factors such as large elderly population,
increasing economic growth, rapidly increasing awareness among individuals regarding
personal wellbeing, government based initiatives promoting oxygen therapy devices and
better health care facilities are the key reasons boosting the market in Brazil and Mexico.
This market is extremely disjointed with numerous big and developing players operating in
the business. The major companies dominating the oxygen therapy devices market in this
region are Chart Industries Inc., Invacare Corporation, Becton, Dickinson and Company,
Smiths Medical, Teleflex Incorporated, Inogen, Inc., DeVilbiss Healthcare, Essex Industries,
Inc., Allied Healthcare Products Inc. and Respan Products Inc.
About Us:
Market Data Forecast is a firm working in the area of market research and business
intelligence. With rich experience in research across various business domains, we cater
to the needs of both individual and corporate clients. Our analyst team comprises expert
professionals in market research, who with their collective knowledge and sksillset
dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: [email protected]
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/pressreleases

Latin America Oxygen Therapy Devices Market was worth USD 0.25 billion in 2016 and estimated to be growing at a CAGR of 6.93%, to reach USD 0.49 billion by 2021.